Brian Grow - 20 Aug 2022 Form 4 Insider Report for Organogenesis Holdings Inc. (ORGO)

Role
Chief Commercial Officer
Signature
/s/ William R. Kolb, Attorney-in-Fact
Issuer symbol
ORGO
Transactions as of
20 Aug 2022
Net transactions value
+$1,175
Form type
4
Filing time
24 Aug 2022, 17:56:55 UTC
Previous filing
05 Apr 2022
Next filing
17 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ORGO Class A Common Stock Options Exercise $1,175 +805 +0.93% $1.46 87,744 20 Aug 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ORGO Stock Option (Right to Buy) Options Exercise $0 -805 -100% $0.000000* 0 20 Aug 2022 Class A Common Stock 805 $1.46 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 100% of the shares subject to the option are fully vested and exercisable.